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Abstract
In this paper, we demonstrate the interpretative power of partial least
square models and how robust interpretability can lead to new quantitative
insights. Interpretability methods for partial least square decomposition are
useful by virtue of PLS being popular in multivariate analysis, describing
specificity of latent variables for corresponding effects.
We discuss the statistical properties of the PLS weights, p values associ-
ated with specific axes, as well as their alignment properties. We present
hierarchical pathway enrichment results stemming from aligned p values,
which are compared with results derived from enrichment analysis, as an
external validation of our method. The applicability of this approach is fur-
ther demonstrated by applying it to both publically available microarray data
from multiple sclerosis and diabetes patients as well as RNA sequencing data
from breast cancer patients.
Our method confers more global, physiologically relevant, knowledge about
the datasets than traditional and more myopic methods.
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1. Introduction
Many fields within “Life Science” bear the suffix “omics”, such as tran-
scriptomics (the study of transcripts), proteomics (the study of proteins), or
metabolomics (the study of metabolites). These characteristically rely upon
clinical trials for human dataset generation, often carrying empty, comple-
mentary or “messy” features as artifacts from their compilation. Trials are
likewise expensive, creates “few samples” but “many features” and generative
methods are dispatched with.
Orthogonal and ordinary Partial Least Squares (PLS) models Wold et al.
(1984); Wegelin (2000) have a long history of usage in metabolomics Rothen-
berg et al. (2019); Eriksson et al. (2013), as well as other fields of research.
The ability to decompose and align the feature space while communicating
the effect of the decomposition on sample space is a well-known property of
PLS models. The PLS methods have long been employed for characterisa-
tion of data features, but the interpretation often stops once the sample and
feature groupings have been identified.
In this work, a pathway is a knowledge-based group descriptor of the
transcripts. It should not be confused with the path diagram of the latent
variables Wegelin (2000). Connecting the weights with axis p-values and
calculating pathway enrichment becomes an important sanity check for this
method. There are several knowledge-based pathway databases Szklarczyk
et al. (2019); Kanehisa and Goto (2000); Jassal et al. (2019); Mi et al. (2018).
These are curated with regards to known activity of transcripts and as such
are not deduced from knowledge inherent in the data. In theory a new and
properly well carried out experiment should be unknown to the knowledge
database curator facilitating the group definitions. As such, if the alignment
of weights to a descriptor axis is sensible then, the pathway enrichments
should convey sensible enrichment for the groups that are under study.
In short for our purposes. Given the feature and sample space description
matrices (X,Y) are described by their corresponding weights (w, c) and
scores (t = Xw,u = Yc). If the PLS algorithm has converged on a solution,
by maximizing covariance between t and u, then w and c will be aligned on
the projected subspace.
In this work we propose a method to detect plausible research targets
by an exploration of the sample space in high entropy domains through
comparative plotting of cosine alignment on Orthogonal Projection to La-
tent Structure (OPLS) Trygg and Wold (2002) decomposition. Further, we
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demonstrate that the PLS decomposition can be directly utilized for: (i) p-
value calculations, (ii) pathway enrichment assessment, (iii) determining the
suppression, or excitation state, of a pathway. We also demonstrate that
weights associated with a simple binary one-hot encoded, multivariate axis
are equivalent to calculating traditional fold changes between those groups.
The paper is structured as follows. Section 2 contextualizes the work.
Section 3 motivates and describes the statistical viewpoint. Section 4 exem-
plifies analysis usage. A number of illustrating analysis examples related to
the previously described method process are then presented in Section 5 in
order to exemplify and validate the proposed solution. Finally, Sections 6
and 7 provide an assessment analysis, conclude from the undertaken experi-
ment.
2. Related Work
Both Principle Component Analysis (PCA) Abdi and Williams (2010)
and PLS create new predictor variables often termed components. The com-
ponents created by PCA maximize the variance in each without regard for
the response. In PCA, we get a large number of components that aim to de-
scribe orthogonal variance. This affine transform can be further exploited to
evaluate the statistical significance of weight relations. Similar to PCA, the
PLS decomposes an input matrix into unique and complementary matrices.
However, unlike PCA, which ultimately relies on factorising a sample centred
expression matrix along the components of maximal orthogonal variance, the
PLS method instead decomposes an input matrix by maximizing the mutual
covariance between the feature space projection against the sample space
response projection on the PLS predictor plane.
The subspace plane could be any dimensionality but is most often two
dimensional such as in PLS regression Rosipal and Krämer (2006). Because
the weights are commonly computed via an iterative procedure it does not
necessarily converge to a good solution, it however often does. Once the
solution has been obtained then the variance in the dataset is often better
described by fewer components than in PCA. It is not strange because the
goal is to model the response by directly decomposing variance onto compo-
nents describing the response. For this reason, a PLS algorithm is similar
to a type-2 linear regression ANalysis Of VAriance (ANOVA) Fisher (1919).
In both methods a two-dimensional tensor is constructed to describe the re-
sponse and as such both methods are prone to similar issues and produce
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similar statistical insights. We will see that, as opposed to a type-2 ANOVA
model, the PLS model also divulge information about the directionality of
the variation along an axis.
Tapp and Kemsley make a point that OPLS regression coefficients used in
ranked analysis do not take advantage of the multivariate nature of OPLS Tapp
and Kemsley (2009). This is correct even for our work, we project the de-
composition down onto a univariate vector to increase the robustness of our
model interpretations.
3. Method
For our adaptation of the OPLS method, we employ the same nomen-
clature as in the work by Rosipal and Krämer (2006). Given the subspace
vectors w ∧ t we assume that any symmetry operations on w will commute
to t. Habitually for our numerical experiments, we treat a set of gene expres-
sions as the feature matrix X and the patient journal, with coarse-grained
end states, as the sample response matrix Y. As such X either represent a
microarray- or a Fragments Per Kilobase of transcript per Million mapped
reads (FPKM) Ribonucleic Acid (RNA)-sequence matrix.
The formulation of groups is done by retrieving journal value entries for
a group present in the statistical formula enclosed with parentheses and a
leading ‘C’. Example
Transcript ∼ C(Group)
would retrieve the Group journal value entries.
Since PLS maximizes the pairwise covariance score, feature weights and
sample weights are “co-linearized” in a similar way. This lets us ascribe
features to sample weights, one way is to employ tessellation. Each transcript
is simply associated with the closest sample axis. This can be either absolute
coordinate proximity on the weight projection plane or the angular proximity
between the transcript and sample axis weight. The formula for calculating
the angular distance is given by the cosine similarity:
d = 1− cos(α) = 1− a · b||a|| · ||b||
Here a, a vector, designates a transcript weight position and b a sample
score weight position, also a vector. The angle α is the angle between a and
b. In summary, we perform the steps:
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1. Use a statistical test formula that defines the group variations to test.
2. Device an encoding data frame from journal group descriptor instances.
3. Utilize OPLS2 to find the solution to the formula using the expression
matrix and patient (sample response) journal.
4. Categorical membership is determined through either tessellation (eu-
clidean distance) or angle, cosine distance to a centroid.
5. Calculate characteristic length scales of the prediction plane by finding
the maximum weights.
6. Calculate the projected density of the weights onto the group axes
defined by the statistical test formula.
7. Calculate p-values for the projections by assuming that the weights are
distributed normally.
8. Calculate the ranking of the weights on the projected axis, mapped in
ascending order from zero to one.
This can be relied upon to visualize how features associate with samples.
As a side note. Since ReactomePA Jassal et al. (2019) knowledge base
is hierarchical, we also employed a hierarchical correction scheme similar to
the elim algorithm as suggested by Alexa et al. (2006).
4. Implementation
We have chosen to employ the OPLS2 algorithm as implemented in the
publically available python Pedregosa et al. (2011) package and it also exists
as an R Geladi and Kowalski (1986); Höskuldsson (1988) package.
All categoricals present in the patient journal are translated into a one-hot
encoding matrix. Thus all and any unique descriptors included in the group
under study gets translated into a unique axis. All formula entries that are
not categoricals are treated as real variables. The exact routine execution is
covered in the supplementary information1.
1Supporting information in experiments.py
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The quantitative analysis relies on projecting the feature weight distribu-
tion onto an axis and studying the point density distribution on that axis.
The p values are calculated from the cumulative error function for the den-
sity along the projection axis, see supplementary code Tjörnhammar (2019a).
The type-2 ANOVA comparison is performed using the statsmodels Seabold
and Perktold (2010) SciPy package.
5. Results
According to the method described in Section 3 we conducted three ex-
periments:
• Multiple Sclerosis (MS) microarray dataset analysis, testing sample
variation to group interaction. Also presenting the alignment properties
of angular PLS model interpretation.
• The Cancer Genome Atlas (TCGA)-BReast CAncer Gene (BRCA)
type-2 ANOVA, deducing the interaction model from the OPLS plot.
Also comparing the analytical strength to type-2 ANOVA.
• Diabetes MICROARRAY dataset compounded analysis with clustering
enrichment for genomic impact in Type 2 Diabetes (T2D).
The datasets for the analysis, as well as the group definition files, can all
be found online Tjörnhammar (2019a). Details of the processing of the MS,
as well as TCGA dataset, is also deposited online Tjörnhammar (2019b).
5.1. Multiple Sclerosis and the alignment properties of PLS models
The Multiple Sclerosis microarray data was obtained via the Gene Expres-
sion Omnibus (GEO) accession number for the microarray dataset GSE219422.
15 ‘Healthy’ controls and 14 ‘MS’ patients were processed and used in the
analysis Kemppinen et al. (2011). The PLS model is conducting the test
whether a transcript sample variation is well described by the between-group
variation. We choose to express this as a statistical formula on the form
Transcript ∼ C(Status)
Here the Status label can take on the values Healthy or MS.
2http://www.ncbi.nlm.nih.gov/geo/
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(a) The OPLS transcript weight
plane with weights coloured by align-
ment to MS state
(b) The OPLS sample scores with
samples coloured by MS state
Figure 1: OPLS model of the MS state.
In Figure 1a we can see how the transcripts become aligned to the dis-
ease state. A large number of transcripts are positioned close to origo and
those that are farther away than 99% of all transcripts are highlighted with
a higher opacity. From Figure 1b, it is clear that the OPLS model separates
the cohort well. By comparing the left and right graph we see that the tran-
script weights are aligned so that we only have significant weights in the same
quadrants as samples. The Y matrix, describing the MS and Healthy sub-
jects sample score weights are also in the same quadrants. We can calculate
the angular proximity between the sample score weights and the transcripts
feature weights and assign what transcripts are closest to a particular score
weight. This allows us to colour the transcripts according to the descriptor
that best captures their variation in the data. We can also define new vectors
corresponding to different directions on the transcript weight plane.
In Figure 2a, we depict the negative logarithm of the OPLS p-values on
the y-axis and fold change values on the x-axis. In this case, the OPLS model
describes the separation between Healthy and MS patients and the p values
are thus analogue to t-test comparison based p values resulting in a volcano
plot appearance. The axis describing the Healthy-Multiple Sclerosis state
variation p values can then be employed to calculate pathway enrichments.
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(a) The gene transcripts associated
OPLS p values and fold changes.
(b) Hierarchically corrected pathway
enrichment.
Figure 2: Sizes corresponds to gene ratios and the significance levels depicted are raw p
values.
In Figure 2b, the pathway enrichment has been calculated using a Fisher
exact test together with the Reactome pathway database. For each pathway,
significant genes are deduced based on a p-value cutoff equal to 0.05 and
a contingency table is produced. The resulting contingency table is then
evaluated using a two-sided Fisher exact test. We choose a two-sided test
because we employ a variational model. As such the enrichment does not
correspond to an up or down-regulated accumulation in the group but rather
correspond to if the group is important in describing the PLS axis.
In Figure 3 we study the gene associations calculated directly from the
PLS feature weights. The feature associations can be calculated from the an-
gle between two transcripts, β, on the transcript PLS weight plane. All pairs
of cos(β) make up an association map for the PLS model. The values range
from +1, for fully aligned, through 0, for orthogonal, to −1 for antialigned.
The PLS solution constructs a model surface that maximizes the variance
between the Y axes. This is the reason why the association map represents
an over accentuated correlation map of the genes depicted.
By selecting a smaller subset of transcripts, here with q < 0.16 values,
and calculating the association map we see that the significant transcripts
8
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(a) The gene transcripts association
map. Colors correspond to the co-
sine of the angle between the feature
weights.
(b) Traditional quantification of the
transcripts with most significant
group differences.
Figure 3: Gene transcription association exploration.
are roughly divided into two anti-associated clusters. Under the assumption
that our coding genes produce proteins, we may utilize string-db Szklar-
czyk et al. (2019) to analyse them. We find that they enrich for immune
system activity in the specific and tertiary granule lumens. The largest clus-
ter enriches for antifungal humoral response and innate immune response in
mucosa while the second cluster enriches for publications on long non-coding
RNA activity. In the second cluster, the gene with the highest intersection
among such publications is the PSMD5 transcript. The protein of this gene
has also been reported for proteomic quantification of differentially expressed
genes between MS and Healthy patients Berge et al. (2019).
5.2. TCGA-BRCA and the comparison with a type-2 ANOVA
In this section we study the TCGA Breast cancer dataset Koboldt et al.
(2012) under OPLS and a type-2 ANOVA. Clinical parameters Tao et al.
(2019), as well as messenger Ribonucleic Acid (mRNA) expression data
from human female patients. Theses were obtained from the TCGA web-
site Koboldt et al. (2012). All of the downloaded samples originated from
9
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(a) Transcript weight colored by their
hormone alignment owners.
(b) The sample scores show that
triple negative patients are diametri-
cally opposed to HER2- & PR+, ER+
patients.
Figure 4: OPLS model of the TCGA breast cancer data set.
Illumina RNA-Seq data using the High Throughput Sequencing (HTS) 3
FPKM workflow Anders et al. (2015). In the case where more than one ex-
pression profile belonged to one sample id we randomly selected one of the
profiles. Sample receptor statuses Ross-Innes et al. (2012) were stored as ER+,
ER-, PR+, PR-, HER2+, HER2- or ND in a sample journal file. This resulted in
1184 breast cancer samples Tjörnhammar (2019b).
In Figure 4 we employed an OPLS model of the form
Transcript ∼ C(HER2) : C(ERPR) + C(HER2) + C(ERPR)
and coloured all the group instances with unique colours. The HER2 group
describes the HER2 receptor state while the Estrogen Receptor Progresterone
Receptor (ERPR) group describes whether or not the ER and PR receptors are
in a particular state. Thus triple-negative patients will belong to the HER2-
& PR-, ER- intergenetion and triple positive to the HER2+ & PR+, ER+. It
is well known that triple-negative patients have a poor survival outcome for
breast cancer and are interesting to study in this context. Figure 4b shows
that triple-negative patients amass in the most southern parts of the lower
quadrants. Diametrically opposed we find the patients bearing the interac-
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(a) Association map of transcripts de-
scribing the variation along the triple
negative axis
(b) Box plots of most significant
transcripts HER2-, PR+, ER+ patients
exhibit starkest differences towards
triple negatives
Figure 5: OPLS model association map of the TCGA breast cancer data set.
tion combination belonging to HER2- & PR+, ER+. We note that the triple-
positive group form an angle of roughly 110 degrees to the triple-negative
group. From here on the call the triple-negative towards HER2-, PR+, ER+
axis the high-risk axis.
Among the genes with the strongest association to the high-risk axis,
we find ESR1, CXXC5, GREB1, FOXA1 and GATA3. They enrich Szklarczyk
et al. (2019) for estrogen-dependent gene expression in Reactome as well as
the prostate gland and uterus development in Biological processes Mi et al.
(2018). We only have women in the data so we safely assume that the
prostate gland enrichment is due to the interaction of these genes with the
progesterone receptor in men.
In Figure 5b, we find the traditional quantification of the transcript data.
Triple-negative patients are remarkably different from the other groups. We
also show both triple-positive as well as HER2-, PR+ and ER+ patient group-
ings. The PLS model in Figure 4b conveyed the information that HER2-, PR+,
ER+ combination are anti associated to the triple negatives and we can also
11
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(a) The p values produced by the PLS
model as well as the intermittent o and
final q values.
(b) OPLS model with all transcripts hav-
ing type-2 ANOVA q < 0.0510455 shown with
full opacity.
see that the biggest difference in the boxplots of Figure 5b is found between
the triple-negative and HER2-, PR+, ER+ group. It is also becomes apparent
that the gene cluster associated with being up in triple-negative patients be-
long to PSAT1, TTL4, FOXC1, USB1, PDSS1, YBX1, KCMF1, YBX1P10 and DSC2.
It constitutes a novel cluster for describing triple-negative patients and it is
only when evaluated along the high-risk axis that the full picture emerges.
These results would not be complete without mentioning the statisti-
cal properties of the weights. Since there is no warranty that PLS models
converge on any specific residual distribution this can become convoluted.
The maximisation of variance on the common subspace plane implies that
a solution would minimize the PLS models squared residual. In using our
formalism we can study the same formula using both an ANOVA as well as
an OPLS model. In Figure 6b we show the same statistical model,
Transcript ∼ C(HER2) : C(ERPR) + C(HER2) + C(ERPR)
produces qualitatively similar results.
In Figure 6a depicts the OPLS model where all the interaction categories
of
Transcript ∼ C(HER2) : C(ERPR)
are shown. The transcripts are also modelled using a type-2 ANOVA and all
12
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transcripts having an interaction with a q < 0.05
10455
are depicted in full opacity.
Two realizations are immediate. The first is that the ANOVA results are
qualitatively similar to those of the OPLS, with a large density of significant
ANOVA transcripts being found on the rim of the OPLS weight plane. Our
OPLS model, however, offers an improvement in that we may determine not
just the specific interaction pair associated with which transcript but also the
direction. From our model, we immediately know that TTLL4 will be scaling
in magnitude with the triple-negative state as well as being significantly
different from the other groupings. The traditional box plot quantification
in Figure 5b is important but not essential. We further explore our PLS
p-values and it is clear from Figure 6a that we have a large accumulation of
weights near the centre. This also means that we are more prone to false
discoveries near the centre. One can directly correct for this in the q value
calculation by assuming that the False Discovery Rate (FDR) scale linearly
with the Fractional Rank (FR) of the list of p values, which is quantified by:
fr(p) =
ranks(p)
length(p)
Instead of assuming a constant FDR Storey and Tibshirani (2003) across p
values, often set equal to 1, for the q value calculation we set it to scale using
the FR formula. These scaled p values are here dubbed o values and are only
used to show the effect of this scaling. The final q values are showed in Fig-
ure 6b. We recognize that the OPLS transcripts with significant interaction
all belong to the rim of the categories defined by the axis studied (here the
far edge of the HER2+, PR-, ER- axis).
5.3. Diabetes Microarray Analysis
Type 2 Diabetes is a metabolic disease on the rise in the general populous.
It is furthermore influenced by both lifestyle choices as well as genetic factors.
Understanding the detailed balance required for this disease phenotype to
emerge is important to achieve better therapies and quality of life of those
affected by it. The understanding of altered metabolism is also of great
importance since many diseases are associated with altered cell and tissue
metabolism Mootha et al. (2003).
There is an increasing amount of evidence that type 2 diabetes T2D, or
Diabetes Mellitus 2 (DM2), disease phenotype constitutes several underlying
metabolic disease phenotypes Ahlqvist et al. (2018).
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Figure 7: T2D & NGT OPLS model with all transcripts.
Here we have chosen to study human DM2 data from the Broad Insti-
tute Mootha et al. (2003). Suspecting that we have more than a single type
of DM2 patients we first segmented the data. This was done by employing
approximative density clustering as implemented in our package Tjörnham-
mar (2019a). Because of the limited number of samples (18) we stopped once
we had obtained the two most separated sample groups. We thereby obtain
two well-separated DM2 cluster types that we name C1.DM2 and C2.DM2 where
the cluster index is the inverted cluster size rank.
In Figure 7 we see that the second cluster consists of only three samples.
They form a group well-separated from the rest but lying close to orthogonal
to the NGT group. The first cluster forms an axis with the NGT group with
weights being positioned opposed to one another. Using our OPLS model
we would believe that they constitute a smaller DM2 phenotype subset with
distinct metabolic alterations. By studying the p-values associations on the
rim of the entire OPLS graph we find that FAM35A have q < 0.05
Ntranscripts
and
aligning with the C1.DM2 axis. FAM35A is known to be a favourable prognostic
marker of glioma and colo-rectal cancer Uhlén et al. (2015). By allowing
ourself to study genes with q < 0.005 we obtain the association map in
Figure 8a.
In Figure 8 we can clearly discern four transcript clusters. The first two
correspond to transcripts that are positively associating with being healthy.
14
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(a) All the edge weight associations
below q < 0.005
(b) The association map of the
largest DM2 group and NGT varia-
tion, q < 0.0001
Figure 8: Complete OPLS association maps.
Those transcripts enrich for Cyclin C activity, which is known for controlling
nuclear cell division Galderisi et al. (2003). The third cluster is positioned
near the centre of the association map on the left and is close to orthogonal
to the other clusters.
This cluster consists of transcripts that enrich Szklarczyk et al. (2019) for
striated muscle contraction Jassal et al. (2019) and organ morphogenesis Mi
et al. (2018). Most of the enrichment signal is, however, coming from the
MYL2, ACTA1, CLDN1, POU4F1, CRX and TNF group. This third cluster belongs
to the C2.DM2 group indicating that these three individuals, albeit being
diabetic, might have dramatically different muscle metabolism.
The first and biggest cluster belong is the C1.DM2 samples visible in Fig-
ure 8. Four transcripts reach high significance and together enrich for ATP
binding activity. The 9 high significance transcripts aligning with this axis
enrich Szklarczyk et al. (2019) for DeoxyriboNucleic Acid (DNA) repair and
DNA metabolism. Taken together with the full C1.DM2-NGT axis transcripts
enrich for activity in the condensed nuclear chromosome. By allowing our-
selves to be less strict and studying enrichments at lower confidence corre-
sponding to the C1.DM2-NGT transcripts in Figure 8a.
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6. Discussion
As a general remark on both our results from Section 5.1 and Section 5.2
is that our p values are larger than the typical two-way ANOVA p < 0.05,
which could indicate that our results are conservative as compared to a two
way ANOVA discovery for the same gene.
6.1. Multiple Sclerosis
From Figure 2 in Section 5.1 we see that the major pathways deduced
are Complex I biogenesis and Neutrophil granulation, pathways which are
affiliated with increased metabolism and immune system activity. Compart-
ment enrichment analysis, also utilizing a two-sided Fisher exact test, of our
p values tells us that the dataset is mainly active in the cytosol, nucleoplasm
and ficolin-1-rich granule membrane. This conveys the picture that we are
dealing with neutrophil degranulation and metabolism of surface membranes.
This is aligned with the common view that MS is associated with demyeli-
nation of axon myelin. Roughly translating into altered lipid metabolism by
the immune system.
Our modelling scheme shows weaker statistical power than other methods
but recovers fundamental and broad descriptive knowledge about the dataset.
We also identify a small subset of significant genes that are differentially
expressed in the cohort and share an intersection with proteomic analysis.
Both the proteomic derived set as well as our PLS transcriptome analysis does
not share a common intersection with the GWAS study published together
with the dataset that we employed. This analysis method should as such be
viewed as a complementary method for producing a data-driven story of the
cohort as well as targets of interest for use in further biological validation.
In this section, we have shown how the Y matrix alignments translate into
the feature space of PLS models.
Looking at Figure 3a and allowing ourself down into the first 100 sig-
nificant PLS genes, with a p < 0.0002 value, we see a common intersection
set between our results and the Berge et al. (2019) proteins. These are TES,
CLTC, SIN3A as well as PSMD5 and known to influence RUNX1 transcription
pathways.
6.2. Breast Cancer
The Forkhead box (FOX) C1 transcript is thought to be a possible target
in nasopharyngeal carcinoma Ou-Yang et al. (2015). FOXA1 is similarly known
16
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Figure 9: T2D & NGT PCA model with all transcripts.
to be correlated with GATA3, Progesteron receptor protein expression and
clinical outcomes in breast cancer Ross-Innes et al. (2012) as well as prostate
cancer Barbieri et al. (2012). However, some of the associations in Figure 5a
are new and might be interesting targets for further biological validation.
It is worth further emphasis that these gene transcripts correspond to the
outliers lying on the axis connecting the triple-negative and the HER2-, PR+,
ER+ in the OPLS feature weight plane.
6.3. Type 2 Diabetes
Hierarchical modelling or agglomerative hierarchical clustering are well-
known methods of partitioning one’s data. Traditionally, building hierar-
chical models are done via curating knowledge and manually constructing a
hierarchy Jassal et al. (2019); Ahlqvist et al. (2018). One can also choose to
computationally construct hierarchical data structures using agglomerative
hierarchical clustering Mehta et al. (2019) or simply try to find the grouping
that will separate the density the most Tjörnhammar (2019a). Approximate
density clustering is similar to agglomerative hierarchical clustering but in-
stead of building a distance hierarchy we try to find the best sample grouping
describing the sample space.
All other things being equal we can compare Figure 7 to Figure 9 and
see that OPLS, by its very nature, better separates the data. In Figure 9
17
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we see that the three samples who have their own cluster in Figure 7 also
correspond to outliers when employing PCA.
Guided by Figure 8 we see an enrichment Szklarczyk et al. (2019) for
Guanosine TriPhosphate (GTP) metabolism in the mitochondria. We know
that mitochondrial GTP metabolism is essential for glucose-dependent in-
sulin secretion Kibbey et al. (2007). It is known that this will lead to dis-
rupted oxidative phosphorylation and an altered mitochondrial membrane
potential Mehta et al. (2019). Furthermore, mitochondria maintain oxidative
phosphorylation by creating a membrane potential, also implying an altered
membrane potential will lead to altered oxidative phosphorylation Mom-
cilovic et al. (2019). This together is indicative that Adenosine TriPhos-
phate (ATP) synthesis might be inhibited, for the diabetics, in the mito-
chondria Sivitz and Yorek (2010). These findings are qualitatively similar to
those reported by Mootha et al. (2003). This is indeed good news since we
are studying people whom, by definition, have inhibited metabolic regulatory
control of glucose and insulin.
7. Conclusions
In and for this article, we have developed a new analysis method, in
Section 3 and code library, as described in Section 4, for use in bioinformatic
analysis. We have demonstrated the use of OPLS models for transcriptomic
analysis on three different mRNA data sets, MS (Section 5.1), TCGA-BRCA
(Section 5.2) and T2D (Section 5.3). Our models produce unbiased sensible
descriptions of the endpoint endogen states where we can relate what we
see in the data to known properties of the human patient samples that we
studied, as discussed in Section 6. We have shown how the alignment of the
sample to feature scores translate into the ability to interpret feature weights
in the context of the sample weights. As such the realization that the weights
of the feature and sample descriptor matrices are aligned facilitates the use
of the feature weights directly in traditional pathway analysis methods. This
also means that a high weight in the direction of a predictor axis will equate
to large, between-group, difference quantifications lying on that axis.
From this, several new and sensible interpretations of the data emerge.
We can also confirm previously known properties of the samples. We find
a gene cluster which follows the triple-negative breast cancer patients which
have interesting suggestion targets for continued validation.
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PLS models are employed in such diverse research fields as financial fore-
casting Huang and Wu (2010), brain imaging Abdi (2010) as well as envi-
ronmental spatial characterization and forecasting Thioulouse et al. (1995).
We believe as such that the method is suitable as decision support for pro-
viding global suggestions of future study in high entropy domains. To our
knowledge, looking at other PLS model applications, no one explores the
orientation, or vector alignment, properties of such models.
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